While the genetic variations in FXS and AS, and in NF1 and TSC, respectively, affect neurodevelopmental pathways in a similar manner, the syndromes are fundamentally different in their origin as well as their phenotypes. This evidence concerns the gene NF1 and fragile X syndrome.